Read all about the latests in HIV/Aids research and treatment protocols and also developments made into various specific components of managing this disease that is by itself also evolving.
Thailand Medical - HIV News May 19, 2023 14 days ago
HIV News: In an unprecedented breakthrough, researchers from Temple University and the University of Nebraska Medical Center (UNMC) have successfully combined a dual gene-editing approach with antiretroviral therapy to effectively eliminate HIV infection in animal models. This potentially revolutionary treatment development, sets the stage for future research aiming at human trials, promising a si...
Medical News - Idiopathic CD4 Lymphocytopenia (ICL) May 09, 2023 24 days ago
Medical News: A groundbreaking 11-year study led by the U.S. National Institute of Allergy and Infectious Diseases that was initiated by Dr Anthony Fauci Nation has exposed shocking insights into idiopathic CD4 lymphocytopenia (ICL), a rare and obscure immune deficiency that leaves individuals susceptible to a myriad of infectious diseases, autoimmune diseases, and cancers.
The study has ...
HIV News - HIV Genomes in Monocytes Apr 12, 2023 2 months ago
HIV News: In the pursuit of HIV eradication, scientists have been examining various hiding places or reservoirs where the virus can store its genetic material. Recent research conducted by a team from Johns Hopkins Medicine has discovered evidence that HIV genomes can persist in a stable reservoir within circulating white blood cells called monocytes. This discovery may provide a new direction for...
HIV News: A new subtype of HIV-1 has emerged, causing rapid decline in immune system function and increasing vulnerability to AIDS and has now been found to have spread globally!
Researchers have discovered a highly virulent variant of subtype-B HIV-1 circulating in the Netherlands, causing alarm in the medical community.
This new HIV strain, known as the "VB variant," is...
HIV News - Hopeaphenol - Viral Reservoirs Mar 29, 2023 2 months ago
The Phytochemical Hopeaphenol , A Natural Stilbenoid, Inhibits HIV Transcription by Targeting Both PKC and NF-κB Signaling and Cyclin-Dependent Kinase 9
HIV News: A new breakthrough discovery in HIV research hold promise in enhancing the efficacy of current HIV treatments and improve the quality for individuals living with HIV.
Researchers from the Wistar Institute, Philadelp...
HIV News - Two Separate Latent HIV Resevoirs Feb 01, 2023 4 months ago
HIV News: Researchers from the University Of North Carolina-United States have discovered that beside the CD4+ cells in blood and lymph tissues that serve as a reservoir for latent HIV, the T Cells in the CNS (Central Nervous System) are also another reservoir for latent HIV virus! This further adds to complications for researchers trying to find a cure for HIV.
Typically, when individual...
HIV News - U.S. FDA Approves Sunlenca (Lenacapavir) For Treatment Resistant HIV Dec 30, 2022 5 months ago
HIV News: The U.S. FDA has of the 22nd of December 2022 granted approval to Gilead Sciences for the usage of its new drug, Sunlenca (Lenacapavir) to treat treatment resistant HIV.
https://www.fda.gov/news-events/press-announcements/fda-approves-new-hiv-drug-adults-limited-treatment-options
Numerous recent HIV News coverages indicate that treatment resistant HIV is becoming a major problem...
HIV News -Long Lasting PrEP Injectables Dec 01, 2022 6 months ago
HIV News: A new injectable PrEP to combat HIV infections and can last for two months has entered the market but unfortunately the cost of the drug was deliberately aimed at HISO sluts and upmarket prostitutes as it cost about US$3,800 per dose or over US$22,000 per person per year in the United States!
The new injectable PrEP called CAB-LA or cabotegravir-long acting was developed and pat...
HIV News - Heart Issues And HIV Nov 29, 2022 6 months ago
HIV News: A new study review led by researchers from Kings College London British Heart Foundation Centre, School of Cardiovascular and Metabolic Medicine & Sciences -UK has found that HIV infections increase risk of cardiovascular issues!
The study team warned that HIV-associated cardiovascular disease is increasing in prevalence, but its mechanisms remain poorly understood.
T...
HIV News: A new study by researcher from Duke University Medical Center, Durham, North Carolina – USA have found that a protein complex called SMC5/6 allows HIV to evade antivirals and immunity.
To date, it is already known that after viral entry and reverse transcription, HIV-1 proviruses that fail to integrate are epigenetically silenced, but the underlying mechanism has remained ...
HIV News - Chronic Inflammation Nov 23, 2022 6 months ago
HIV News: A new study by researchers from The George Washington University - USA, University of Melbourne - Australia and Massachusetts General Hospital, Harvard Medical School, Boston – USA have found that a HIV protein called Nef causes permanent changes to immune cells, leading to chronic inflammation and associated co-morbidities including cardiovascular issues.
According to the...
Source: Medical News - COVID-19 -HIV Oct 14, 2022 8 months ago
A new study led by researchers from Johns Hopkins Bloomberg School of Public Health has found that HIV patients with moderately low CD4 cell counts risk severe breakthrough COVID-19 infections.
The study team said that understanding the severity of postvaccination SARS-CoV-2 (ie, COVID-19) breakthrough illness among individuals with HIV (PWH) can inform vaccine guidelines and risk-reducti...
Source: Medical News - Simian arteriviruses Oct 05, 2022 8 months ago
A new U.S. NIH sponsored study has shockingly found that a primate hemorrhagic fever-causing arterivirus from Africa has acquired the necessary mutations to cross over into the human species using the CD162 receptors for cellular entry.
It should be noted that the African continent is a hub for various emerging pathogens and diseases and in fact, one theory that has not been properly expl...
Source: COVID-19 Induced Immunodeficiency Jun 19, 2022 12 months ago
COVID-19 Induced Immunodeficiency: When Thailand Medical News as early as April 2020 warned and highlighted studies that SARS-CoV-2 infections could cause immunodeficiency conditions similar to those seen in HIV infections, we were ridiculed by many Western media and so called Western ‘garbage’ experts and even labelled as fake news by various America social media platforms!
https:/...
A new study by researchers from University of Kansas Medical Center-USA has found that the envelope protein of SARS-Cov-2 potently inhibits HIV-1 infection!
It has been found that the human coronavirus SARS-CoV-2 encodes for a small 75 amino acid transmembrane proteins known collectively as the envelope (E) protein.
The E protein forms an ion channel, like the viroporins from human immunod...
VB HIV Variant: An international team of researchers led by Oxford University-UK And Stichting HIV Monitoring Research Institute-Netherlands have discovered an alarming new highly virulent HIV variant in Netherlands that is fast spreading around Europe. The new variant replicates faster causing high viral loads, attacks and depletes the CD4 cells more aggressively and rapidly, and was found t...
SARS-CoV-2-HIV: Researchers from University of Chicago-USA and Northwestern University, Chicago-USA have in a new study uncovered the similarities and differences between SARS-CoV-2 And HIV-1 infections in terms of cellular and immune responses.
The key findings of the study show that:
-Both COVID-19 and HIV-1+ patients show disease-specific inflammatory immune signatures
-CO...
A new study by researchers from the University of California Los Angeles (UCLA) has found that ApoA-I mimetic peptides, a type of anti-inflammatory and antioxidant peptides derived from tomato extract can reduce intestinal inflammation related to being infected with HIV.
There is a dire need for novel therapeutic strategies are to attenuate increased systemic and gut inflammation that contribute ...
Source: Medical News - Omicron Updates Dec 06, 2021 2 years ago
Omicron Updates: While many countries around the world are still seeing new winter surges due to the Delta variant and its emerging sub-variants, the Omicron variant has now been detected in a total of 43 countries around the world and is causing an increase of cases in Denmark, UK and US via local transmissions.
In France, the Delta variant is now causing a surge due to the emergence of n...
Source: SARS-CoV-2 Mutations-Immune Evasion Oct 25, 2021 2 years ago
SARS-CoV-2 Mutations-Immune Evasion: A new study by researchers from the Data Science Department, SOPHiA GENETICS-Switzerland has found that mutations at a hotspot W152 of the N-Terminal Domain (NTD) of the SARS-CoV-2 virus is driving immune evasion.
The study team reported a striking increase in the frequency of recruitment of diverse substitutions at a critical residue (W152), positioned...
HIV-COVID-19: Numerous case studies are emerging that special attention needs to be paid to HIV patients should they contract the COVID-19 disease as their immunocompromised conditions make them perfect ‘vivo laboratories’ for the SARS-CoV-2 to constantly mutate and develop more potent and worrisome mutations and resultant variants.
In one case study published on a preprint server by ...
HIV News: A new international study led by the University of Southern California, involving various other research entities including University of Cape Town-South Africa,Thai Red Cross AIDS Research Centre-Thailand, University of Amsterdam-Netherlands, Washington University School of Medicine-USA, Missouri University of Novi Sad-Serbia ,University of New South Wales-Australia, University of Calif...
HIV News: A new collaborative international HIV study has shown that Dolutegravir, the current first-line treatment for HIV, may not be as effective as hoped in sub-Saharan Africa.
The research finds that this so-called 'wonder drug' may be less effective in patients resistant to older drugs.
The research findings were published in the peer reviewed journal: Nature Communications. ...
HIV News: University of British Columbia researchers have concluded a new study of which the findings are set to change international treatment recommendations for individuals who are newly diagnosed with HIV, an update that could affect nearly two million people per year worldwide.
The research found that the antiviral dolutegravir is the optimal medication for first-line treatment for i...
HIV Drugs: According to researchers from the University of Washington-Seattle, the commonly used HIV drug that is to treat those infected and also individuals using it as a prophylaxis or in PrEP protocols can induce a type I/III interferon-associated signature and inflammation throughout the gut.
It should be noted that long term inflammation of any kind can lead to a variety of chronic ...
HIV News: Researchers from University of Michigan Health System have discovered that a class of antibiotics called pleicomacrolides allows the immune system to kill HIV infected cells by inhibiting the Nef proteins.
The research finds are published in the Journal of The Proceedings of the National Academy Of Sciences of The United States Of America (Concanamycin A counteracts HIV-1 Nef to...
HIV News: The trend for HIV drug research is now shifting towards drugs with long lasting effects without the need for HIV patients to adhere to stringent daily regimens and doses which can be quiet stressful at times.
Scientists from the University of Utah Health in collaboration with researchers from the National Institute of Allergy and Infectious Diseases (NIAID), Beth Israel Deacones...
HIV Drug News: Researchers at the George Washington University in a new study have discovered that Fingolimod, a US FDA-approved immunosuppressive drug used to treat multiple sclerosis flare-ups, may be used to effectively block HIV infection and reduce the latent virus reservoir.
The research findings were published in the journal: PLOS Pathogens. https://journals.plos.org/plospathogens/...
HIV Research: The significant impact and prevalence of heart disease and other critical comorbidities on an aging global population with human immunodeficiency virus (HIV) have emerged from a suite of articles in The Journal of Infectious Diseases that contains the first swath of important data from the world's largest study of cardiovascular disease (CVD) prevention in people with H...
COVID-19 And HIV: Individuals with HIV who were hospitalized with COVID-19 did not have worse results than COVID-19 patients without HIV, according to new research by Icahn School of Medicine at Mount Sinai.
The research findings were published in the journal: Clinical Infectious Diseases https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa880/5864410?searchresult=1
Study...
HIV Drugs: The drug Rukobia (fostemsavir) has been approved by The U.S. FDA for adults living with HIV who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations.
Rukobia (Fostemsavir) is a new type of antiretroviral medication to be taken twice daily by mouth. It is a prodrug, whi...
Source: HIV and Lenacapavir Jul 02, 2020 3 years ago
HIV and Lenacapavir: Gilead scientists are reporting an early step toward an HIV drug that could potentially be taken only a couple of times per year.
A new study showed that a single injection of the experimental drug, called lenacapavir, was able to lower blood levels of HIV in a small group of patients. And it was capable of maintaining active levels in the blood for more than six...
HIV: Immunology researchers from the Yerkes National Primate Research Center and the Emory Vaccine Center (EVC) are first to show a new adjuvant, 3M-052, helps induce long-lasting immunity against HIV.
The research findings are published today in the journal: Science Immunology. https://immunology.sciencemag.org/content/5/48/eabb1025
Significantly, in this pre-clinical study&n...
HIV: Medical researchers from Rush University Medical Center, Temple University School of Medicine and the University Of Texas Medical Branch have found that astrocytes, a type of brain cell can harbor HIV and then spread the virus to immune cells that traffic them out of the brain and into other organs.
It was observed that HIV moved from the brain via this route even when the virus was ...
HIV Research: Medical researchers have known for a long time that despite the advancements in antiretroviral therapy, varying amounts HIV virus remains in infected individuals forever, hiding in small reservoirs of cells of the immune system. Should ever these individuals discontinue the antiretroviral therapy, the HIV virus almost always rebounds rapidly from the reservoirs, causing deadly sympto...
Source : Thailand Medical News Feb 19, 2020 3 years ago
Non-alcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD) and is characterized by liver inflammation and cell damage. It is a potentially dangerous condition that can progress to cirrhosis or liver cancer. Unfortunately, HIV patients tend to have a high prevalence of the disease.
A new study by McGill University, Canada has found that Vitamin E can ...
Source: Thailand Medical News Feb 01, 2020 3 years ago
Typically antiretroviral drugs are the gold standard for the treatment of HIV infection. They are highly effective in suppressing replication of the virus but require lifelong daily application and can be associated with side effects. Due to the high mutability of HIV and its capacity for rapid adaptation, combinations of antiretroviral agents are required to prevent the development of drug resist...
Source: Thailand Medical News Jan 23, 2020 3 years ago
More than 42 million people are infected with HIV worldwide, about 1.5 million people in the United States alone. Currently, people with HIV take antiretroviral therapy (ART), which can suppress HIV to undetectable levels in blood, but the virus persists throughout the body in latently infected resting CD4+ T cells. The immune system cannot recognize these cells and no current therapies can elimin...
Source: Thailand Medical News Jan 09, 2020 3 years ago
A research discovery by Florida State University College of Medicine researchers is expected to open the door for new and more potent treatment options for many of the more than 45 million people worldwide infected with the HIV virus and for others chronically ill with hepatitis B.
Professor Dr Zucai Suo of the FSU College of Medicine. Credit: Colin Hackley/FSU
Their study has established for t...
Source: Thailand Medical News Jan 07, 2020 3 years ago
New nonhuman primate research suggests for the first time that a single dose of an antibody-based treatment can prevent HIV transmission from mother to baby. The findings are being published in the journal Nature Communications.
The time or period when that single dose is given is key, however. The study found rhesus macaque newborns did not develop the monkey form of HIV, called SHIV, whe...
Source: Thailand Medical News Dec 18, 2019 4 years ago
Despite early antiretroviral therapy, or ART, has ensured less deadly outcomes for children living with and exposed to HIV, studies show the virus still may affect the brain. HIV may disrupt neurodevelopment, affecting how children learn, reason and function.
Dr Michael Boivin, professor and director of the Psychiatry Research Program in the Michigan State University College of Osteopathic Medi...
Source: Thailand Medical News Dec 12, 2019 4 years ago
A study of human cells and tissues by researchers at the National Institutes of Health and the University of Bologna, Italy has shown that Nano-sized vesicles released by certain bacteria that inhabit the vagina may protect against HIV infection.
Typically known as extracellular vesicles, these bubble-like particles are produced by many kinds of cells and are thought to transport molecules...
Source: Thailand Medical News Nov 30, 2019 4 years ago
For babies are born with HIV, starting treatment within hours to days is critical and important according to a new study led by researchers from Harvard. Unfortunately the norm in many countries is to wait for weeks or even months.
The study findings, from a small but unique study in Botswana, could influence care in Africa and other regions hit hard by the virus. They also might offer a ...
Source: Thailand Medical News Nov 25, 2019 4 years ago
Researchers at Scripps Research, California and the nonprofit vaccine research organization IAVI who are developing an experimental HIV vaccine has reached an important milestone by eliciting antibodies that can neutralize a wide variety of HIV strains.
The tests, in animal models,showed that these “broadly neutralizing” antibodies, or bnAbs, targeted at least two critical sites on ...
Source: Thailand Medical News Nov 21, 2019 4 years ago
Despite a few past research studies that links HIV with 'erosion" of the gut's intestinal linings, leading to inflammation and also the ‘leaky gut” syndrome, many HIV patients and even doctors are not aware of this.
In one past research in 2014, researchers at University of California, Davis had made some surprising discoveries about the body's initial response...
Source: Thailand Medical News Nov 15, 2019 4 years ago
In a study by researchers from Johns Hopkins University School of Medicine comparing medical information from portable EKG patch data from men living with HIV and also men without it, the researchers report they have found more variability of the electrical "reset" period between heartbeats known as the QT interval in men living with the virus, which may contribute to the increased...
Source: Thailand Medical News Nov 11, 2019 4 years ago
A new study demonstrates that women with HIV are more likely to enter the menopause transition at an average age of 48 years, 3 years younger than the general population. Study results are published online in Menopause, the journal of The North American Menopause Society (NAMS).
Typically, newly diagnosed HIV-positive patients who adhere to the latest therapy protocols are expected to...
Source: Thailand Medical News Nov 10, 2019 4 years ago
A group of medical and genomic researchers in Maryland from a company called American Gene Technologies announced that they have the answer for curing HIV/AIDS using gene therapy. The company hopes to initiate medical trials of a new gene therapy drug that it says can cure HIV.
American Gene Technologies (AGT), a Rockville-based medical research company, has submitted a Investigational New...
Source: Thailand Medical News Nov 07, 2019 4 years ago
Abbott announced today that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1 Group M, subtype L.1 The findings, published today in the Journal of Acquired Immune Deficiency Syndromes (JAIDS), show the role next-generation genome sequencing is playing in helping researchers stay one step ahead of mutating viruses and avoiding n...
Source: Thailand Medical News Oct 26, 2019 4 years ago
Medical researchers from the US National Institutes of Health and the Massachusetts General Hospital (MGH) in Boston report that the injectable hormone tesamorelin (Egrifta) reduces liver fat and prevents liver fibrosis (scarring) in people living with HIV.
Dr Anthony S. Fauci,NIAID Director (NIAID is one of the entities under the NIH) commented in a phone interview with Thailand Medical ...
Source: Thailand Medical News Oct 24, 2019 4 years ago
From 2007 to 2018, there has been more than 37 studies that show that Selenium supplementation is good for HIV patients. Selenium supplementation has demonstrated the ability to reduce viral loads of the HIV virus while also preventing CD4 levels from declining and helping it achieve moderate gains.
Todate, there are been no known reactions or contraindications for those taking antiretrov...
Source: Thailand Medical News Oct 23, 2019 4 years ago
An new research study involving an international collaboration that included the University of Cape Town (UCT), Centre for the AIDS Program of Research in South Africa (CAPRISA) and the University of North Carolina at Chapel Hill (UNC) has revealed an unexpected finding that could lead to better therapies towards reducing the HIV reservoir, a major barrier to developing a cure for HIV. The reservo...
Source: Thailand Medical News Oct 05, 2019 4 years ago
The US FDA has approved second PrEXp (pre-exposure prophylaxis) drug, Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg) to help prevent HIV infections. The drug is for in at-risk adults and adolescents weighing at least 35kg for HIV-1 pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection from sex, excluding those who have receptive vaginal sex. Descovy is not indicated...
Source: Thailand Medical News Sep 25, 2019 4 years ago
Thailand Medical News is pleased to present this simple guide with regards to essential micronutrients, health supplements and herbal products for people living with HIV. It is not mean for anyone to abstain from their prescribed antiretroviral therapies and before commencing any consumption any of these products, always consult your doctors first.
Micronutrients
All vitamins and minerals are ...
Source: Thailand Medical News Sep 24, 2019 4 years ago
CAR-T, a type of immunotherapy may have made its name as the cancer breakthrough of this century, but its roots dig far back to one of humanity’s other terrifying medical enemy: HIV. CAR-T is a type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient’s blood. Then t...
.jpg)
.jpg)
